Kiera Heffernan

2PUBLICATIONS
0CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|Aug 24, 2023
Outcomes of dostarlimab versus chemotherapy in post-platinum patients with recurrent/advanced endometrial cancer: data from the GARNET trial and the National Cancer Registration Service in England.

Scott Goulden, Kiera Heffernan, Fulya Sen Nikitas

Pageof 1

Frequent Collaborators